Abcm Corporation (ABCM): Price and Financial Metrics
GET POWR RATINGS... FREE!
ABCM POWR Grades
- Sentiment is the dimension where ABCM ranks best; there it ranks ahead of 89.76% of US stocks.
- The strongest trend for ABCM is in Momentum, which has been heading down over the past 179 days.
- ABCM ranks lowest in Momentum; there it ranks in the 14th percentile.
ABCM Stock Summary
- Abcam plc's stock had its IPO on October 22, 2020, making it an older stock than merely 2.29% of US equities in our set.
- With a price/earnings ratio of 720.99, Abcam plc P/E ratio is greater than that of about 98.97% of stocks in our set with positive earnings.
- Price to trailing twelve month operating cash flow for ABCM is currently 59.38, higher than 91.67% of US stocks with positive operating cash flow.
- If you're looking for stocks that are quantitatively similar to Abcam plc, a group of peers worth examining would be FTEK, IOSP, OFLX, MGIC, and ENZ.
- To dig deeper into the stock's financial statements, go to ABCM's page on browse-edgar?action=getcompany&CIK=0001492074.
ABCM Stock Price Chart Interactive Chart >
ABCM Price/Volume Stats
| Current price | $14.26 | 52-week high | $24.00 |
| Prev. close | $13.98 | 52-week low | $12.54 |
| Day low | $14.07 | Volume | 105,400 |
| Day high | $14.37 | Avg. volume | 155,660 |
| 50-day MA | $16.54 | Dividend yield | N/A |
| 200-day MA | $19.43 | Market Cap | 3.26B |
Abcm Corporation (ABCM) Company Bio
Abcm Corporation operates rehabilitation centers, long-term care facilities, and independent and assisted living communities. The Company offers out-patient therapy, independent and assisted living, skilled nursing and rehabilitative care, dementia care, family respite care, respite services, and home care. ABCM serves patients throughout the United States.
Latest ABCM News From Around the Web
Below are the latest news stories about Abcam plc that investors may wish to consider to help them evaluate ABCM as an investment opportunity.
Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research ApplicationsCAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif., February 01, 2022--Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announced a licensing agreement under which Abcam will use a proprietary Twist VHH phage library for antibody discovery, development and commercialization for diagnostic an |
Is Abcam plc (LON:ABC) Trading At A 20% Discount?Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by projecting its future... |
Alamar Biosciences partners with Abcam to drive understanding of the human proteomeAlamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of the human proteome. |
Immunoprotein Diagnostic Testing Market Is Booming Worldwide 2021-2028 | Abbott Laboratories, Inc., Abcam PLC, Agilent TechnologiesAnother factual information on the "Immunoprotein Diagnostic Testing Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the |
Bradycardia Drugs Market Report: Production Capacity And Consumption Analysis By Regions And Country Wise Forecast Report 2022-2027 | Alkaloids of Australia, Abcam, Albany Molecular Research, Alchem InternationalLos Angeles, United State, ,- This research study is one of the most detailed and accurate ones that solely focus on the global Bradycardia Drugs market. It sheds light on critical factors that impact the growth of the global Bradycardia |
ABCM Price Returns
| 1-mo | -17.09% |
| 3-mo | -12.41% |
| 6-mo | -36.48% |
| 1-year | -29.02% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -39.45% |
| 2021 | 9.28% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...